
Join us for our upcoming MARWALL Asia webinar: Opportunity and challenges in R/R ALL, featuring keynote speakers Daniel DeAngelo (USA) and David Marks (UK) together with our esteemed regional experts. Learn about the latest updates in the management of relapsed or refractory acute lymphoblastic leukemia (R/R ALL), including clinical considerations for hematopoietic stem cell transplantation (HSCT).
Faculty


Agenda


This forum is strictly meant for Healthcare Professionals (HCPs) only. Accessing and/or dissemination of this information beyond HCPs is restricted and not allowed. If you are not the intended recipient, you should delete this message and any disclosure, copying, or distribution of this message, or the taking of any action based on it, by you is strictly prohibited.
Pfizer Corporation Hong Kong Limited21/F, Kerry Centre, 683 King’s Road, Quarry Bay, Hong Kong
Tel: 852 2811 9711 Fax: 852 2579 0599 Website: www.Pfizer.com.hk
Organized by the Pfizer Emerging Markets Oncology Medical Team.
Copyright © 2022 Pfizer Inc. All rights reserved
EM-CHN-ino-0003
